Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1864

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351864)

Label for Venlafaxine ER 37.5 mg extended release capsules, packaged by Bryant Ranch Prepack in Burbank, CA. The label states the product is a gray/peach capsule, compares it to Effexor XR 37.5 mg capsules by Aurobindo Pharma Limited, and indicates a package size of 30 capsules. Storage instructions specify room temperature between 20°-25°C (68°-77°F), and a warning mentions it may cause drowsiness. The product NDC is 71335-1864-41.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A chart showing pharmacokinetic (PK) fold changes of venlafaxine with various interacting drugs. It plots Cmax and AUC values with 90% confidence intervals, accompanied by recommendations for concomitant use, including dose adjustment and cautions for specific drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A chart illustrating drug interaction effects on pharmacokinetics (PK) parameters such as Cmax and AUC for various interacting drugs with Venlafaxine Hydrochloride. It plots PK fold changes with 90% confidence intervals and includes recommendations on dose adjustments or cautions for each interacting drug.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A forest plot chart illustrating pharmacokinetic changes in Venlafaxine Hydrochloride related to special populations, such as hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. The chart shows fold changes with 90% confidence intervals for analytes venlafaxine and ODV regarding Cmax and AUC, alongside dosing recommendations based on these changes.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular framework including aromatic ring, cyclohexane ring, hydroxyl group, and dimethylamino ethyl side chain with an HCl molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.